High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA Regimen) : Preliminary Results of a Phase 2a Study

Min Wu, Yunxiang Zhang, Wen Wu,Zheng Ge,Ligen Liu,Chunyan Ji, Weiying Gu, Chunling Wang, Yanli Zhang,Wei Yang,Fuling Zhou, Zhengping Yu, Min Ji,Banghe Ding, Shudong Wang, Lijun Wei, Hengwen Song, Yan Zhou, Bomin Yin, Zhichao Shao, Mengdan Sun, Qi Jiang, Junjie Lu,Junmin Li

Blood（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined